[Immunotherapy of squamous cell carcinoma of the bovine eye and of equine sarcoid].

The research article explores the use of immunotherapy, specifically BCG injections, in treating squamous cell carcinomas in bovine eyes and equine sarcoids. The study showed varied results with the best outcome resulting in permanent regression of the tumor after a single injection in 37% of cattle, and complete regression in 70-80% of equine sarcoids cases.

Understanding the Research

• The main aim of this research is to evaluate the effectiveness of BCG (Bacillus Calmette-Guerin) immunotherapy in treating squamous cell carcinomas of the bovine eye and equine sarcoids.
• Squamous cell carcinomas are a type of cancer that begin in the squamous cells present in the tissue that forms the surface of the skin, the lining of hollow organs in the body, and the passages of the respiratory tract and digestive tract. In this case, the carcinomas are in the eyes of cattle.
• Equine sarcoids are skin tumors that occur in horses and are known to be the most common type of skin cancer in horses.

Analysis of BCG Immunotherapy

• The method of immunotherapy used in this research involves the injection of BCG into the tumor. BCG is a vaccine that is commonly used to prevent Tuberculosis (TB). The application of BCG as an immunotherapy is based on its ability to stimulate an immune response against cancer cells.
• This study recorded different responses to BCG therapy. In some cases, there was a permanent regression of the lesion in about 37 per cent of cattle after a single administration. However, in another 26 per cent, the regression was followed by a recurrence of the tumor. Unfortunately, in 37 per cent of the cattle, the tumor continued to grow despite the BCG treatment.
• The research suggests that the recurrence may be preventable by repeated injections into the lesion.

Comparison with Equine Sarcoids

• In contrast to the results in bovine eyes, equine sarcoids showed a high rate of complete regression, between 70-80 per cent, with BCG immunotherapy.
• However, there was a different response observed in tumors on the limbs of the horses. These showed a less satisfactory response to the treatment, with lower success rates and more complications, compared to tumors in other areas of the horse’s body.

Conclusion

• This research provides valuable evidence in understanding the potential effectiveness of BCG immunotherapy in treating specific kinds of cancers in animals. However, the varied responses and potential complications indicate that further research and refinement are needed in this field.